CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 27 filers reported holding CORREVIO PHARMA CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $26,000 | +62.5% | 66,112 | +64.8% | 0.00% | – |
Q4 2019 | $16,000 | -15.8% | 40,112 | +329.4% | 0.00% | – |
Q3 2019 | $19,000 | -83.6% | 9,341 | -82.5% | 0.00% | -100.0% |
Q2 2019 | $116,000 | +84.1% | 53,518 | +167.3% | 0.00% | 0.0% |
Q1 2019 | $63,000 | +425.0% | 20,018 | +328.4% | 0.00% | – |
Q4 2018 | $12,000 | +50.0% | 4,673 | +132.8% | 0.00% | – |
Q3 2018 | $8,000 | -33.3% | 2,007 | -35.6% | 0.00% | – |
Q2 2018 | $12,000 | – | 3,117 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 250,000 | $103,000 | 0.68% |
Tamarack Advisers, LP | 2,500,000 | $1,019,000 | 0.23% |
Virtu Financial LLC | 287,972 | $118,000 | 0.01% |
ARS Investment Partners, LLC | 147,818 | $61,000 | 0.01% |
Pacifica Partners Inc. | 2,665 | $1,000 | 0.00% |
K.J. Harrison & Partners Inc | 12,860 | $5,000 | 0.00% |
OXFORD ASSET MANAGEMENT LLP | 116,653 | $48,000 | 0.00% |
UBS Group AG | 24,006 | $10,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 11,430 | $5,000 | 0.00% |